Implantica AG Receivables

The latest receivables for IMP-A-SDB.ST is $3.2M as of June 2026. That compares with $500K in the prior-year period — up 537.5% year over year. Investors often review this figure alongside Implantica AG's historical trend and sector peers before judging valuation or financial health.

Over the past year, IMP-A-SDB.ST's receivables moved from $500K to $3.2M — a 537.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Implantica AG's operating scale or balance-sheet position.

A receivables figure of $3.2M for IMP-A-SDB.ST is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting IMP-A-SDB.ST's receivables ($3.2M), review year-over-year change from $500K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.